0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Invasive Neuromodulatory Devices Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18J15209
Home | Market Reports | Health| Medical Devices & Equipment
Global Non Invasive Neuromodulatory Devices Market Research Report 2023
BUY CHAPTERS

Global Non-Invasive Neuromodulatory Devices Market Research Report 2025

Code: QYRE-Auto-18J15209
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Invasive Neuromodulatory Devices Market

The global market for Non-Invasive Neuromodulatory Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Non-Invasive Neuromodulation is neuromodulation that does not require a surgical procedure, such as TMS, TENS, ECT, or tES.
North American market for Non-Invasive Neuromodulatory Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-Invasive Neuromodulatory Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-Invasive Neuromodulatory Devices include Neuroelectrics, Aneuvo, Soterix Medical, Magstim, BrainsWay, ElectroCore Medical, NeuroCare Group, Koninklijke Philips, NESA World, DEYMED Diagnostic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Neuromodulatory Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Neuromodulatory Devices.
The Non-Invasive Neuromodulatory Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Invasive Neuromodulatory Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Neuromodulatory Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-Invasive Neuromodulatory Devices Market Report

Report Metric Details
Report Name Non-Invasive Neuromodulatory Devices Market
Segment by Type
Segment by Application
  • Hospitals & Clinics
  • Cognitive Care Centers
  • Research Institutes
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Neuroelectrics, Aneuvo, Soterix Medical, Magstim, BrainsWay, ElectroCore Medical, NeuroCare Group, Koninklijke Philips, NESA World, DEYMED Diagnostic, electroCore, Medistar, Vagustim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-Invasive Neuromodulatory Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-Invasive Neuromodulatory Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-Invasive Neuromodulatory Devices Market report?

Ans: The main players in the Non-Invasive Neuromodulatory Devices Market are Neuroelectrics, Aneuvo, Soterix Medical, Magstim, BrainsWay, ElectroCore Medical, NeuroCare Group, Koninklijke Philips, NESA World, DEYMED Diagnostic, electroCore, Medistar, Vagustim

What are the Application segmentation covered in the Non-Invasive Neuromodulatory Devices Market report?

Ans: The Applications covered in the Non-Invasive Neuromodulatory Devices Market report are Hospitals & Clinics, Cognitive Care Centers, Research Institutes, Others

What are the Type segmentation covered in the Non-Invasive Neuromodulatory Devices Market report?

Ans: The Types covered in the Non-Invasive Neuromodulatory Devices Market report are Transcutaneous Supraorbital Neurostimulation, Single-Pulse Transcranial Magnetic Stimulation, Non-invasive Vagal Nerve Stimulation, Others

Recommended Reports

Neurostimulation Devices

Neuromodulation Market

Neurovascular Devices

1 Non-Invasive Neuromodulatory Devices Market Overview
1.1 Product Definition
1.2 Non-Invasive Neuromodulatory Devices by Type
1.2.1 Global Non-Invasive Neuromodulatory Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Transcutaneous Supraorbital Neurostimulation
1.2.3 Single-Pulse Transcranial Magnetic Stimulation
1.2.4 Non-invasive Vagal Nerve Stimulation
1.2.5 Others
1.3 Non-Invasive Neuromodulatory Devices by Application
1.3.1 Global Non-Invasive Neuromodulatory Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals & Clinics
1.3.3 Cognitive Care Centers
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Non-Invasive Neuromodulatory Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Neuromodulatory Devices Revenue 2020-2031
1.4.2 Global Non-Invasive Neuromodulatory Devices Sales 2020-2031
1.4.3 Global Non-Invasive Neuromodulatory Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-Invasive Neuromodulatory Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Neuromodulatory Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-Invasive Neuromodulatory Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-Invasive Neuromodulatory Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Product Type & Application
2.7 Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Date of Enter into This Industry
2.8 Global Non-Invasive Neuromodulatory Devices Market Competitive Situation and Trends
2.8.1 Global Non-Invasive Neuromodulatory Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-Invasive Neuromodulatory Devices Players Market Share by Revenue
2.8.3 Global Non-Invasive Neuromodulatory Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Invasive Neuromodulatory Devices Market Scenario by Region
3.1 Global Non-Invasive Neuromodulatory Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-Invasive Neuromodulatory Devices Sales by Region: 2020-2031
3.2.1 Global Non-Invasive Neuromodulatory Devices Sales by Region: 2020-2025
3.2.2 Global Non-Invasive Neuromodulatory Devices Sales by Region: 2026-2031
3.3 Global Non-Invasive Neuromodulatory Devices Revenue by Region: 2020-2031
3.3.1 Global Non-Invasive Neuromodulatory Devices Revenue by Region: 2020-2025
3.3.2 Global Non-Invasive Neuromodulatory Devices Revenue by Region: 2026-2031
3.4 North America Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.4.1 North America Non-Invasive Neuromodulatory Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-Invasive Neuromodulatory Devices Sales by Country (2020-2031)
3.4.3 North America Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Neuromodulatory Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-Invasive Neuromodulatory Devices Sales by Country (2020-2031)
3.5.3 Europe Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Neuromodulatory Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Non-Invasive Neuromodulatory Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-Invasive Neuromodulatory Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-Invasive Neuromodulatory Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Neuromodulatory Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-Invasive Neuromodulatory Devices Sales by Country (2020-2031)
3.7.3 Latin America Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Neuromodulatory Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-Invasive Neuromodulatory Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Neuromodulatory Devices Sales by Type (2020-2031)
4.1.1 Global Non-Invasive Neuromodulatory Devices Sales by Type (2020-2025)
4.1.2 Global Non-Invasive Neuromodulatory Devices Sales by Type (2026-2031)
4.1.3 Global Non-Invasive Neuromodulatory Devices Sales Market Share by Type (2020-2031)
4.2 Global Non-Invasive Neuromodulatory Devices Revenue by Type (2020-2031)
4.2.1 Global Non-Invasive Neuromodulatory Devices Revenue by Type (2020-2025)
4.2.2 Global Non-Invasive Neuromodulatory Devices Revenue by Type (2026-2031)
4.2.3 Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Type (2020-2031)
4.3 Global Non-Invasive Neuromodulatory Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-Invasive Neuromodulatory Devices Sales by Application (2020-2031)
5.1.1 Global Non-Invasive Neuromodulatory Devices Sales by Application (2020-2025)
5.1.2 Global Non-Invasive Neuromodulatory Devices Sales by Application (2026-2031)
5.1.3 Global Non-Invasive Neuromodulatory Devices Sales Market Share by Application (2020-2031)
5.2 Global Non-Invasive Neuromodulatory Devices Revenue by Application (2020-2031)
5.2.1 Global Non-Invasive Neuromodulatory Devices Revenue by Application (2020-2025)
5.2.2 Global Non-Invasive Neuromodulatory Devices Revenue by Application (2026-2031)
5.2.3 Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Application (2020-2031)
5.3 Global Non-Invasive Neuromodulatory Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Neuroelectrics
6.1.1 Neuroelectrics Company Information
6.1.2 Neuroelectrics Description and Business Overview
6.1.3 Neuroelectrics Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Neuroelectrics Non-Invasive Neuromodulatory Devices Product Portfolio
6.1.5 Neuroelectrics Recent Developments/Updates
6.2 Aneuvo
6.2.1 Aneuvo Company Information
6.2.2 Aneuvo Description and Business Overview
6.2.3 Aneuvo Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aneuvo Non-Invasive Neuromodulatory Devices Product Portfolio
6.2.5 Aneuvo Recent Developments/Updates
6.3 Soterix Medical
6.3.1 Soterix Medical Company Information
6.3.2 Soterix Medical Description and Business Overview
6.3.3 Soterix Medical Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Soterix Medical Non-Invasive Neuromodulatory Devices Product Portfolio
6.3.5 Soterix Medical Recent Developments/Updates
6.4 Magstim
6.4.1 Magstim Company Information
6.4.2 Magstim Description and Business Overview
6.4.3 Magstim Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Magstim Non-Invasive Neuromodulatory Devices Product Portfolio
6.4.5 Magstim Recent Developments/Updates
6.5 BrainsWay
6.5.1 BrainsWay Company Information
6.5.2 BrainsWay Description and Business Overview
6.5.3 BrainsWay Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BrainsWay Non-Invasive Neuromodulatory Devices Product Portfolio
6.5.5 BrainsWay Recent Developments/Updates
6.6 ElectroCore Medical
6.6.1 ElectroCore Medical Company Information
6.6.2 ElectroCore Medical Description and Business Overview
6.6.3 ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ElectroCore Medical Non-Invasive Neuromodulatory Devices Product Portfolio
6.6.5 ElectroCore Medical Recent Developments/Updates
6.7 NeuroCare Group
6.7.1 NeuroCare Group Company Information
6.7.2 NeuroCare Group Description and Business Overview
6.7.3 NeuroCare Group Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NeuroCare Group Non-Invasive Neuromodulatory Devices Product Portfolio
6.7.5 NeuroCare Group Recent Developments/Updates
6.8 Koninklijke Philips
6.8.1 Koninklijke Philips Company Information
6.8.2 Koninklijke Philips Description and Business Overview
6.8.3 Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Koninklijke Philips Non-Invasive Neuromodulatory Devices Product Portfolio
6.8.5 Koninklijke Philips Recent Developments/Updates
6.9 NESA World
6.9.1 NESA World Company Information
6.9.2 NESA World Description and Business Overview
6.9.3 NESA World Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NESA World Non-Invasive Neuromodulatory Devices Product Portfolio
6.9.5 NESA World Recent Developments/Updates
6.10 DEYMED Diagnostic
6.10.1 DEYMED Diagnostic Company Information
6.10.2 DEYMED Diagnostic Description and Business Overview
6.10.3 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Product Portfolio
6.10.5 DEYMED Diagnostic Recent Developments/Updates
6.11 electroCore
6.11.1 electroCore Company Information
6.11.2 electroCore Description and Business Overview
6.11.3 electroCore Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 electroCore Non-Invasive Neuromodulatory Devices Product Portfolio
6.11.5 electroCore Recent Developments/Updates
6.12 Medistar
6.12.1 Medistar Company Information
6.12.2 Medistar Description and Business Overview
6.12.3 Medistar Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Medistar Non-Invasive Neuromodulatory Devices Product Portfolio
6.12.5 Medistar Recent Developments/Updates
6.13 Vagustim
6.13.1 Vagustim Company Information
6.13.2 Vagustim Description and Business Overview
6.13.3 Vagustim Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vagustim Non-Invasive Neuromodulatory Devices Product Portfolio
6.13.5 Vagustim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Neuromodulatory Devices Industry Chain Analysis
7.2 Non-Invasive Neuromodulatory Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Neuromodulatory Devices Production Mode & Process Analysis
7.4 Non-Invasive Neuromodulatory Devices Sales and Marketing
7.4.1 Non-Invasive Neuromodulatory Devices Sales Channels
7.4.2 Non-Invasive Neuromodulatory Devices Distributors
7.5 Non-Invasive Neuromodulatory Devices Customer Analysis
8 Non-Invasive Neuromodulatory Devices Market Dynamics
8.1 Non-Invasive Neuromodulatory Devices Industry Trends
8.2 Non-Invasive Neuromodulatory Devices Market Drivers
8.3 Non-Invasive Neuromodulatory Devices Market Challenges
8.4 Non-Invasive Neuromodulatory Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-Invasive Neuromodulatory Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-Invasive Neuromodulatory Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-Invasive Neuromodulatory Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-Invasive Neuromodulatory Devices Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-Invasive Neuromodulatory Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-Invasive Neuromodulatory Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-Invasive Neuromodulatory Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-Invasive Neuromodulatory Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-Invasive Neuromodulatory Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Neuromodulatory Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-Invasive Neuromodulatory Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-Invasive Neuromodulatory Devices Sales by Region (2020-2025) & (Units)
 Table 18. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Non-Invasive Neuromodulatory Devices Sales by Region (2026-2031) & (Units)
 Table 20. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Non-Invasive Neuromodulatory Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-Invasive Neuromodulatory Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-Invasive Neuromodulatory Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-Invasive Neuromodulatory Devices Sales by Country (2020-2025) & (Units)
 Table 27. North America Non-Invasive Neuromodulatory Devices Sales by Country (2026-2031) & (Units)
 Table 28. North America Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-Invasive Neuromodulatory Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-Invasive Neuromodulatory Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-Invasive Neuromodulatory Devices Sales by Country (2020-2025) & (Units)
 Table 32. Europe Non-Invasive Neuromodulatory Devices Sales by Country (2026-2031) & (Units)
 Table 33. Europe Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-Invasive Neuromodulatory Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-Invasive Neuromodulatory Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-Invasive Neuromodulatory Devices Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Non-Invasive Neuromodulatory Devices Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Non-Invasive Neuromodulatory Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-Invasive Neuromodulatory Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-Invasive Neuromodulatory Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-Invasive Neuromodulatory Devices Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Non-Invasive Neuromodulatory Devices Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-Invasive Neuromodulatory Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-Invasive Neuromodulatory Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-Invasive Neuromodulatory Devices Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Non-Invasive Neuromodulatory Devices Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Non-Invasive Neuromodulatory Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-Invasive Neuromodulatory Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-Invasive Neuromodulatory Devices Sales (Units) by Type (2020-2025)
 Table 51. Global Non-Invasive Neuromodulatory Devices Sales (Units) by Type (2026-2031)
 Table 52. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Non-Invasive Neuromodulatory Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-Invasive Neuromodulatory Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-Invasive Neuromodulatory Devices Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-Invasive Neuromodulatory Devices Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-Invasive Neuromodulatory Devices Sales (Units) by Application (2020-2025)
 Table 61. Global Non-Invasive Neuromodulatory Devices Sales (Units) by Application (2026-2031)
 Table 62. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Non-Invasive Neuromodulatory Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Non-Invasive Neuromodulatory Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-Invasive Neuromodulatory Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-Invasive Neuromodulatory Devices Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-Invasive Neuromodulatory Devices Price (US$/Unit) by Application (2026-2031)
 Table 70. Neuroelectrics Company Information
 Table 71. Neuroelectrics Description and Business Overview
 Table 72. Neuroelectrics Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Neuroelectrics Non-Invasive Neuromodulatory Devices Product
 Table 74. Neuroelectrics Recent Developments/Updates
 Table 75. Aneuvo Company Information
 Table 76. Aneuvo Description and Business Overview
 Table 77. Aneuvo Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Aneuvo Non-Invasive Neuromodulatory Devices Product
 Table 79. Aneuvo Recent Developments/Updates
 Table 80. Soterix Medical Company Information
 Table 81. Soterix Medical Description and Business Overview
 Table 82. Soterix Medical Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Soterix Medical Non-Invasive Neuromodulatory Devices Product
 Table 84. Soterix Medical Recent Developments/Updates
 Table 85. Magstim Company Information
 Table 86. Magstim Description and Business Overview
 Table 87. Magstim Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Magstim Non-Invasive Neuromodulatory Devices Product
 Table 89. Magstim Recent Developments/Updates
 Table 90. BrainsWay Company Information
 Table 91. BrainsWay Description and Business Overview
 Table 92. BrainsWay Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BrainsWay Non-Invasive Neuromodulatory Devices Product
 Table 94. BrainsWay Recent Developments/Updates
 Table 95. ElectroCore Medical Company Information
 Table 96. ElectroCore Medical Description and Business Overview
 Table 97. ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ElectroCore Medical Non-Invasive Neuromodulatory Devices Product
 Table 99. ElectroCore Medical Recent Developments/Updates
 Table 100. NeuroCare Group Company Information
 Table 101. NeuroCare Group Description and Business Overview
 Table 102. NeuroCare Group Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. NeuroCare Group Non-Invasive Neuromodulatory Devices Product
 Table 104. NeuroCare Group Recent Developments/Updates
 Table 105. Koninklijke Philips Company Information
 Table 106. Koninklijke Philips Description and Business Overview
 Table 107. Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Koninklijke Philips Non-Invasive Neuromodulatory Devices Product
 Table 109. Koninklijke Philips Recent Developments/Updates
 Table 110. NESA World Company Information
 Table 111. NESA World Description and Business Overview
 Table 112. NESA World Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. NESA World Non-Invasive Neuromodulatory Devices Product
 Table 114. NESA World Recent Developments/Updates
 Table 115. DEYMED Diagnostic Company Information
 Table 116. DEYMED Diagnostic Description and Business Overview
 Table 117. DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Product
 Table 119. DEYMED Diagnostic Recent Developments/Updates
 Table 120. electroCore Company Information
 Table 121. electroCore Description and Business Overview
 Table 122. electroCore Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. electroCore Non-Invasive Neuromodulatory Devices Product
 Table 124. electroCore Recent Developments/Updates
 Table 125. Medistar Company Information
 Table 126. Medistar Description and Business Overview
 Table 127. Medistar Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Medistar Non-Invasive Neuromodulatory Devices Product
 Table 129. Medistar Recent Developments/Updates
 Table 130. Vagustim Company Information
 Table 131. Vagustim Description and Business Overview
 Table 132. Vagustim Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Vagustim Non-Invasive Neuromodulatory Devices Product
 Table 134. Vagustim Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Non-Invasive Neuromodulatory Devices Distributors List
 Table 138. Non-Invasive Neuromodulatory Devices Customers List
 Table 139. Non-Invasive Neuromodulatory Devices Market Trends
 Table 140. Non-Invasive Neuromodulatory Devices Market Drivers
 Table 141. Non-Invasive Neuromodulatory Devices Market Challenges
 Table 142. Non-Invasive Neuromodulatory Devices Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-Invasive Neuromodulatory Devices
 Figure 2. Global Non-Invasive Neuromodulatory Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-Invasive Neuromodulatory Devices Market Share by Type: 2024 & 2031
 Figure 4. Transcutaneous Supraorbital Neurostimulation Product Picture
 Figure 5. Single-Pulse Transcranial Magnetic Stimulation Product Picture
 Figure 6. Non-invasive Vagal Nerve Stimulation Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Non-Invasive Neuromodulatory Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Non-Invasive Neuromodulatory Devices Market Share by Application: 2024 & 2031
 Figure 10. Hospitals & Clinics
 Figure 11. Cognitive Care Centers
 Figure 12. Research Institutes
 Figure 13. Others
 Figure 14. Global Non-Invasive Neuromodulatory Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Non-Invasive Neuromodulatory Devices Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Non-Invasive Neuromodulatory Devices Sales (2020-2031) & (Units)
 Figure 17. Global Non-Invasive Neuromodulatory Devices Average Price (US$/Unit) & (2020-2031)
 Figure 18. Non-Invasive Neuromodulatory Devices Report Years Considered
 Figure 19. Non-Invasive Neuromodulatory Devices Sales Share by Manufacturers in 2024
 Figure 20. Global Non-Invasive Neuromodulatory Devices Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Non-Invasive Neuromodulatory Devices Players: Market Share by Revenue in Non-Invasive Neuromodulatory Devices in 2024
 Figure 22. Non-Invasive Neuromodulatory Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Non-Invasive Neuromodulatory Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Non-Invasive Neuromodulatory Devices Sales Market Share by Country (2020-2031)
 Figure 25. North America Non-Invasive Neuromodulatory Devices Revenue Market Share by Country (2020-2031)
 Figure 26. United States Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Non-Invasive Neuromodulatory Devices Sales Market Share by Country (2020-2031)
 Figure 29. Europe Non-Invasive Neuromodulatory Devices Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Non-Invasive Neuromodulatory Devices Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Non-Invasive Neuromodulatory Devices Revenue Market Share by Region (2020-2031)
 Figure 37. China Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Non-Invasive Neuromodulatory Devices Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Non-Invasive Neuromodulatory Devices Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Non-Invasive Neuromodulatory Devices Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Non-Invasive Neuromodulatory Devices Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Non-Invasive Neuromodulatory Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Non-Invasive Neuromodulatory Devices by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Non-Invasive Neuromodulatory Devices by Type (2020-2031)
 Figure 56. Global Non-Invasive Neuromodulatory Devices Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Non-Invasive Neuromodulatory Devices by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Non-Invasive Neuromodulatory Devices by Application (2020-2031)
 Figure 59. Global Non-Invasive Neuromodulatory Devices Price (US$/Unit) by Application (2020-2031)
 Figure 60. Non-Invasive Neuromodulatory Devices Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart